TMCnet News
New developments from Integra LifeSciences outlined recently(Life Science Weekly Via Thomson Dialog NewsEdge) New developments from Integra LifeSciences outlined recently. This trend article is an immediate alert from NewsRx to identify the most recent news developments at Integra LifeSciences. Report 1: Integra LifeSciences Holding Corporation (Nasdaq:IART) and IDA Ireland announced today the opening of its global manufacturing facility in Tullamore, Co Offaly, Ireland, to produce the CUSA(R) Excel ultrasonic aspirator, a surgical device for the precise destruction of tissue that is used for tumor removal procedures and many other complex surgical operations. Irish Minister for Finance Brian Cowen TD officiated at the opening of the new facility and announced that the company intends to create 65 highly skilled engineering and other technical positions, with the support of IDA Ireland (Industrial Development Agency). Welcoming today's announcement, Minister Cowen said, "Integra LifeSciences is a pioneer in its industry. In the last 2 years, it launched almost 20 new products. It is a highly sophisticated advanced manufacturing operation and heavily reliant on high skills, knowledge and expertise. It is a dominant player in the growing neuro surgical and neuro trauma market and its products are recognised as being among the technological leaders in its field. Integra is a company at the cutting-edge of industry and is a superb addition to the Midlands and to the medical technology industry base in Ireland." The Minister continued, "In 2004, Integra established a shared services centre in Blanchardstown, Dublin to support its European manufacturing and sales activities. Due to the success of this venture, and following discussions with IDA Ireland, the company chose Ireland to further expand its activities. We faced strong competition for this investment and we are delighted this decision was taken for Ireland and for the Midlands. We are very confident that Integra will continue to experience the great success and achievements in Tullamore that it has to date in Ireland." Report 2: Integra LifeSciences Holdings Corp. (IART) announced the launch of the Mobius Multi Modality Monitoring System as the latest addition to Integra's neuromonitoring product line. The Mobius system has received 510(k) clearance from the United States Food & Drug Administration. The Mobius Multi Modality Monitoring System is designed to complement Integra's existing neuromonitoring product lines by providing a single interface for monitoring multiple neurological and other parameters. The Mobius system serves as a physical and communication hub for existing Integra monitoring systems, such as the Camino and LICOX systems that measure intracranial pressure, temperature, and oxygen in the brain, and the patient's bedside monitor. The Mobius system also provides secure data archiving capabilities and multimedia-based instructional content pertaining to the use of Integra's monitoring products. By connecting their existing monitoring systems to the Mobius system, physicians and clinical staff will be able to simultaneously view, trend, analyze, and archive for study many relevant neuromonitoring parameters, including intracranial pressure (ICP), oxygen, cerebral perfusion pressure (CPP), temperature, cerebral blood flow, and systemic arterial pressure. In addition, the Mobius system provides guidelines and step-by-step, multimedia-driven setup and usage instructions for Integra's extensive neuromonitoring product line, as well as quick reference access to the entire Brain Trauma Foundation guidelines, according to the company. "The Mobius Multi Modality Monitoring System allows neurosurgeons, intensivists, and other clinicians to extract various acute physiological parameters that impact cerebral oxygenation from the bed-side monitors together with ICP, CPP, brain tissue oxygenation, and brain temperature from the neuromonitoring equipment," said Pradeep Narotam, MD, FACS, assistant professor at the division of neurosurgery at Creighton University Medical Center. Report 3: Integra LifeSciences Holdings Corp. (IART) announced that Jerry E. Corbin has been named principal accounting officer, replacing David B. Holtz in that role. Corbin joined the company earlier this year as vice president, corporate controller. In addition, David Holtz, Integra's senior vice president, finance, has notified Integra he will be leaving Integra at the end of the year to pursue other opportunities. Corbin joined Integra in June 2006. From 1989-2006, Corbin held key finance positions in corporate accounting, sales, and marketing and, most recently, research and development for sanofi-aventis and its predecessors. Copyright 2007 Life Science Weekly via NewsRx.com |